Copyright
©The Author(s) 2021.
World J Clin Cases. Mar 6, 2021; 9(7): 1600-1609
Published online Mar 6, 2021. doi: 10.12998/wjcc.v9.i7.1600
Published online Mar 6, 2021. doi: 10.12998/wjcc.v9.i7.1600
Number | IGF-1 | After therapy | Fold change | IGFBP3 | After therapy | Fold change |
3 | 283 | 453 | 1.60 | 4.4 | 6.3 | 1.43 |
5 | 101 | 266 | 2.63 | 3.4 | 4.8 | 1.41 |
6 | 98.7 | 149 | 1.51 | 2.9 | 3 | 1.03 |
7 | 461 | 527 | 1.14 | 5.2 | 5.3 | 1.02 |
8 | 31.2 | 63.5 | 2.04 | 1.1 | 2.3 | 2.09 |
11 | 238 | 220 | 0.92 | 4.5 | 4.1 | 0.91 |
17 | 572 | 603 | 1.05 | 6.4 | 5.6 | 0.88 |
18 | 306 | 340 | 1.11 | 5.3 | 4.8 | 0.91 |
22 | 101 | 118 | 1.17 | 3.6 | 3.2 | 0.89 |
24 | 86 | 160 | 1.86 | 3.5 | 3.7 | 1.06 |
27 | 119 | 196 | 1.65 | 3.2 | 4.7 | 1.47 |
29 | 414 | 464 | 1.12 | 4.8 | 3.2 | 0.67 |
31 | 175 | 246 | 1.41 | 4.2 | 4.1 | 0.98 |
38 | 27.4 | 184 | 6.72 | 2 | 4.8 | 2.40 |
- Citation: Yang LL, Liang SS. Study on pathogenic genes of dwarfism disease by next-generation sequencing. World J Clin Cases 2021; 9(7): 1600-1609
- URL: https://www.wjgnet.com/2307-8960/full/v9/i7/1600.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i7.1600